Clinical Trial Update: Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials evaluating LP-98 for injection in HIV-infected patients were completed, reporting pharmacokinetics and preliminary efficacy data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• LP-98

Snippet

Sponsor: Shanxi Kangbao Biological Product Co., Ltd. | Conditions: Hiv | Phase 1, Phase 2 | Status: COMPLETED